1. Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients
    Xu Liu et al, 2017, Medicine CrossRef
  2. Markers of Inflammation and Incident Breast Cancer Risk in the Women’s Health Study
    Deirdre K Tobias et al, 2017 CrossRef
  3. Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?
    Marie Colombe Agahozo et al, 2018, Mod Pathol CrossRef
  4. Cyclin-Dependent Kinases as Coregulators of Inflammatory Gene Expression
    M. Lienhard Schmitz et al, 2016, Trends in Pharmacological Sciences CrossRef
  5. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer
    Zhenhua Huang et al, 2018, BMC Cancer CrossRef
  6. Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment
    Katerina Pilatova et al, 2018, Cancer Immunol Immunother CrossRef
  7. Association between low-grade inflammation and Breast cancer and B-cell Myeloma and Non-Hodgkin Lymphoma: findings from two prospective cohorts
    Eloise Berger et al, 2018, Sci Rep CrossRef
  8. Role of Tumor Microenvironment in Cancer Stem Cell Chemoresistance and recurrence
    Madhurima Das et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  9. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study
    N. Martínez et al, 2018, Clin Transl Oncol CrossRef
  10. HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
    Diana P. Saraiva et al, 2018, Front. Immunol. CrossRef
  11. Three gold indicators for breast cancer prognosis: a case–control study with ROC analysis for novel ratios related to CBC with (ALP and LDH)
    Noha Mohamed Said, 2019, Mol Biol Rep CrossRef
  12. The role of inflammation and its related microRNAs in breast cancer: A narrative review
    Alireza Bahiraee et al, 2019, J Cell Physiol CrossRef
  13. Utility of Red Cell Distribution Width as a Prognostic Factor in Young Breast Cancer Patients
    Du-Ping Huang et al, 2016, Medicine CrossRef
  14. Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis
    Lubov A. Tashireva et al, 2017, Immunobiology CrossRef
  15. Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment
    Radoslaw Bednarek et al, 2019, Breast Cancer Res Treat CrossRef
  16. Anti‐inflammatory effect from extracts of Red Chinese cabbage and Aronia in LPS‐stimulated RAW 264.7 cells
    Jung Hyun Kwak et al, 2020, Food Sci Nutr CrossRef
  17. Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy
    Charu Kothari et al, 2018, Oncotarget CrossRef

  18. Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer


    Tewodros Shibabaw et al, 2020, BCTT CrossRef
  19. Collagen production and niche engineering: A novel strategy for cancer cells to survive acidosis in DCIS and evolve
    Mehdi Damaghi et al, 2020, Evol Appl CrossRef
  20. Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers
    Ji Won Woo et al, 2020, Cancer Immunol Immunother CrossRef
  21. Effects of Brief Stress Management Interventions on Distress and Leukocyte Nuclear Factor Kappa B Expression During Primary Treatment for Breast Cancer: a Randomized Trial.
    Alain Diaz et al, 2021, Psychoneuroendocrinology CrossRef
  22. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients
    Elham Safarzadeh et al, 2021, Front. Immunol. CrossRef
  23. Hymenolepis diminuta-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progression
    Scott Sauer et al, 2021 CrossRef
  24. Molecular Interaction Analysis of COX-2 Against Aryl Amino Alcohol Derivatives from Isoeugenol as Anti Breast Cancer using Molecular Docking
    Zulfa Zuhrufa et al, 2021, Bull. Chem. React. Eng. Catal. CrossRef
  25. Preoperative Routine Laboratory Markers for Predicting Postoperative Recurrence and Death in Patients with Breast Cancer
    Young-Chul Yoo et al, 2021, JCM CrossRef
  26. Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study
    Anjali Gupta et al, 2021, Oncotarget CrossRef
  27. ERα36–GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells
    George Notas et al, 2021, IJMS CrossRef
  28. Identifying GPSM Family Members as Potential Biomarkers in Breast Cancer: A Comprehensive Bioinformatics Analysis
    Huy-Hoang Dang et al, 2021, Biomedicines CrossRef
  29. Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling
    Fengjie Liu et al, 2021, Mediators of Inflammation CrossRef
  30. Hyaluronan Functions in Wound Repair That Are Captured to Fuel Breast Cancer Progression
    Cornelia Tolg et al, 2021, Biomolecules CrossRef
  31. Greenspace, Inflammation, Cardiovascular Health, and Cancer: A Review and Conceptual Framework for Greenspace in Cardio-Oncology Research
    Jean C. Bikomeye et al, 2022, IJERPH CrossRef
  32. Image processing improvements afford second-generation handheld optoacoustic imaging of breast cancer patients
    Jan Kukačka et al, 2022, Photoacoustics CrossRef
  33. T helper cell-mediated epitranscriptomic regulation via m6A RNA methylation bridges link between coronary artery disease and invasive ductal carcinoma
    Sudeshna Rakshit et al, 2022, J Cancer Res Clin Oncol CrossRef
  34. A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs
    Valeria Villarreal-García et al, 2022, Front. Oncol. CrossRef
  35. Dual-Activated Nano-Prodrug for Chemo-Photodynamic Combination Therapy of Breast Cancer
    Ziyao Lu et al, 2022, IJMS CrossRef
  36. Everybody needs good neighbours: the progressive DCIS microenvironment
    Shayin V. Gibson et al, 2023, Trends in Cancer CrossRef
  37. Bibliometric analysis of worldwide research trends on breast cancer about inflammation
    Guangran Meng et al, 2023, Front. Oncol. CrossRef
  38. Relationship between Inflammatory Markers Combined with TILs and Neoadjuvant Efficacy in Breast Cancer
    腾超 傅, 2023, ACM CrossRef
  39. Inflammatory indicators as a prognostic factor of clinical response in locally advanced breast cancer (LABC) patients receiving neoadjuvant chemotherapy (NAC)
    Sonar Soni Panigoro et al, 2024, Revista de Senología y Patología Mamaria CrossRef
  40. Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation
    Jin-Hee Lee et al, 2024, Arch. Pharm. Res. CrossRef
  41. Dietary Inflammatory Index, Dietary Non-Enzymatic Antioxidant Capacity, and Colorectal and Breast Cancer Risk (MCC-Spain Study)
    Mireia Obón-Santacana et al, 2019, Nutrients CrossRef
  42. Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells
    Ege Arzuk et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef